 BEVERLY HILLS, Calif., Dec. 17, 2020 PRNewswire -- GT Biopharma, Inc. OTCQB: GTBP GTBP.PA a company focused on developing innovative therapeutic treatments based on its proprietary NK cell engager TriKETM platform, announced today that Cytovance, a USA-based contract development... 